Community/Retail

To avoid the tax pitfalls of procrastination, here are 4 accounting and tax tips to implement!

Gray market diagnostic OTC medical devices pose substantial health and safety risks to patients.

The role of the pharmacist should be made known to our patients and the community.

The FDA approved betrixaban on June 23 as the first oral agent for the prevention of VTE prophylaxis in hospitalized medically ill adults

The opioid crisis is a major concern worldwide, with overdoses accounting for the number 1 cause of accidental deaths in the United States.

Bevyxxa has been approved based on data from Portola's phase 3 APEX Study.

Levi Smith, PharmD, MS, PhD Candidate at Yale University highlights the path of a drug from target discovery all the way to clinical uses and applications.

Digital Eye Strain (also known as computer vision syndrome) and blue light is not something I imagine is covered in many colleges of pharmacy across the country. It is the physical discomfort that is felt after spending more than two hours in front of a digital device screen. In addition to eyestrain, symptoms of computer vision syndrome can include: headaches, blurred vision, dry eye, neck and shoulder pain. Although the use of any digital device can cause digital eye strain, according to The Vision Council, devices that are most commonly used are: desktop computers, laptop computers, televisions, smartphones, tablets, and video games. In the age of technology, digital eye strain is something that all pharmacists should know about; not only to help patients protect their vision, but to help protect and preserve their own vision.

Summer is here, and pharmacists may be considering trying new and exciting activities.

The approval is based on multiple clinical trials, and provides patients with a subcutaneous option for rituximab that shortens the treatment time to 5 to 7 minutes compared with intravenous infusion.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

McKesson Specialty Health has entered into a definitive agreement to acquire intraFUSION, a Houston-based provider of management services for physician office infusion centers.

The Journal of Continuing Education in the Health Professions has published a study that assessed the effect of interprofessional education (IPE) on the quality of diabetes care.

Pharmacy Times and Parata Systems, founding partners of the Next-Generation Pharmacist awards, have announced this year’s 30 finalists.

The discussions at the Advisory Committee meeting were based on data from the LEADER trial.

Researchers from Jawaharlal Nehru University in New Delhi, India studied an array of natural medicinal products with beneficial effects on mitochondria or redox stabilization.

CVS Health has been recognized by Points of Light, the world's largest organization dedicated to volunteer service, as one of the fifty most community-minded companies in the United States.

Mydayis is not for use in children 12 years and younger.

All drugs are good and bad depending on the situation.

The FDA has approved Cotempla XR-ODT (methylphenidate) extended-release orally disintegrating tablets from Neos Therapeutics, the company announced in a press release.

Pharmacists appear to have a better understanding of penicillin allergies than other health care professionals, according to study that included 276 surveys completed by non-allergist physicians, nurse practitioners, and pharmacists at Rochester Regional Health.

We asked Jeffrey R. Aeschlimann, PharmD, an infectious disease specialist who is on the faculty of the University of Connecticut's Schools of Medicine and Pharmacy, to answer questions about drug interactions in patients with HIV.

Tom Frank, PharmD, BCPS, Director of Research and Education at the University of Arkansas for Medical Sciences, discusses what advice pharmacists can offer parents who are trying to determine if their child is suffering from cold or allergy symptoms.

Tom Frank, PharmD, BCPS, Director of Research and Education at the University of Arkansas for Medical Sciences, talks about what special considerations pharmacists should have when advising patients who are seeking allergy medicine for their children?

New fluoroquinolone provides options for serious skin infection treatment.